Academic Journal
A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
العنوان: | A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results |
---|---|
المؤلفون: | King, Brett, Guttman-Yassky, Emma, Peeva, Elena, Banerjee, Anindita, Sinclair, Rodney, Pavel, Ana B., Zhu, Linda, Cox, Lori Ann, Craiglow, Brittany, Chen, Linda, Banfield, Christopher, Page, Karen, Zhang, Weidong, Vincent, Michael S. |
المساهمون: | Pfizer |
المصدر: | Journal of the American Academy of Dermatology ; volume 85, issue 2, page 379-387 ; ISSN 0190-9622 |
بيانات النشر: | Elsevier BV |
سنة النشر: | 2021 |
المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1016/j.jaad.2021.03.050 |
الاتاحة: | http://dx.doi.org/10.1016/j.jaad.2021.03.050 https://api.elsevier.com/content/article/PII:S0190962221006010?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0190962221006010?httpAccept=text/plain |
Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by-nc-nd/4.0/ |
رقم الانضمام: | edsbas.CBEA394C |
قاعدة البيانات: | BASE |
DOI: | 10.1016/j.jaad.2021.03.050 |
---|